Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031)
Value
Estimated—
Awarded—
Who already wins at this buyer
Firms with recorded awards from Ministry of Social Affairs and Health in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Sanofi Oy | 1 | €11,088,000 | 2026-09-08 |
| Viatris Oy | 1 | €9,710,400 | 2026-07-06 |
| MSD Finland Oy | 1 | €5,097,600 | 2026-09-08 |
Full buyer profile: what Ministry of Social Affairs and Health buys and who wins it →
CPV codes
33651600 Medical equipment & pharmaceuticals33600000 Medical equipment & pharmaceuticals33650000 Medical equipment & pharmaceuticalsDescription
The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV+Hib) vaccine, required for the vaccinations in the National Immunisation Program in Finland. The contract period is one (1) year during 2027 - 2028. The procurement contains three (3) one (1) -year contract period renewals (1 + 1 + 1) to extend the contract for the years 2029, 2030 and 2031. Estimated quantity for the contract period including contract period renewals is 560,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2025 SUPPLIES Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service Annex 6 Bank Details Annex 7 Quality Agreement
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-08 | Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031) | Ministry of Social Affairs and Health FI | 100% |
| 2026-07-06 | Seasonal Influenza vaccine 2026-2027 (2027-2028) | Ministry of Social Affairs and Health FI | 95% |
| 2026-09-08 | Measles, mumps and rubella (MMR) vaccine 2027-2028 (2029, 2030) | Ministry of Social Affairs and Health FI | 94% |
| 2026-08-27 | Supply and Delivery of 6 in 1 (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Inactivated Polio Vaccine, Haemophilus Influenza Type B Conjugate) Vaccine | Health Service Executive (HSE) IE | 91% |
| 2026-06-18 | Negotiated Procedure for the supply of Diphtheria, Tetanus, Pertussis (Acellular Component), Poliomyelitis (Inactivated), Hepatitis B (rDNA) and Haemophilus influenzae B conjugate vaccine (adsorbed) | Central Procurement and Supplies Unit (MFH) MT | 89% |
| 2026-08-26 | Supply and Delivery of Human Seasonal Trivalent Influenza Vaccines | Health Service Executive (HSE) IE | 89% |